Nicotine, Transdermal Patch
Recommended · restricted PainAuthority RequiredNot applicable line
as an aid to cessation of smoking in patients who have entered or are entering a comprehensive support and counselling program in the context of a public health priority area
1
Submissions
2010–10
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Mar 2010Recommended · restricted
vs varenicline
- PBS listing · Authority Required
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-analysis provided (not full economic evaluation with ICER). Document states 'nicotine patches are less effective, of superior safety and less expensive than varenicline' but no numeric ICER calculated.
Cost-effectiveness accepted
Decision context
Populationsmokers motivated to quit smoking
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Mar 2010 | Recommended · restricted | varenicline | — | RCT, Meta-analysis · Continuous abstinence rate (CAR) |